Andrew Hirsch
2020 - Agios Pharmaceuticals
In 2020, Andrew Hirsch earned a total compensation of $2.9M as Former Chief Financial Officer at Agios Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,508,875 |
|---|---|
| Salary | $361,234 |
| Stock Awards | $618,120 |
| Other | $397,893 |
| Total | $2,886,122 |
Hirsch received $1.5M in option awards, accounting for 52% of the total pay in 2020.
Hirsch also received $361.2K in salary, $618.1K in stock awards and $397.9K in other compensation.
Rankings
In 2020, Andrew Hirsch's compensation ranked 4,010th out of 13,090 executives tracked by ExecPay. In other words, Hirsch earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,010 out of 13,090 | 69th |
Division Manufacturing | 1,615 out of 5,620 | 71st |
Major group Chemicals And Allied Products | 615 out of 2,253 | 73rd |
Industry group Drugs | 531 out of 1,953 | 73rd |
Industry Pharmaceutical Preparations | 405 out of 1,458 | 72nd |
Pay ratio
| Andrew Hirsch's Pay | $2,886,122 |
|---|---|
| Median Employee's Pay | $253,211 |
| Pay Ratio | 11to 1 |
In 2020, the annual total compensation of Andrew Hirsch was $2,886,122.
The annual total compensation of the median employee at Agios Pharmaceuticals was $253,211.
The ratio of Andrew Hirsch's pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 8, 2021.
Hirsch's colleagues
We found four more compensation records of executives who worked with Andrew Hirsch at Agios Pharmaceuticals in 2020.